S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Critical asset just had biggest fall on record (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Critical asset just had biggest fall on record (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Critical asset just had biggest fall on record (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Critical asset just had biggest fall on record (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app

Smith & Nephew (SN) Stock Forecast & Price Target

GBX 1,092.50
-9.00 (-0.82%)
(As of 02/9/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability

Smith & Nephew Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 6 Analyst Ratings

Analysts' Consensus Price Target

GBX 1,361.60
High ForecastGBX 1,500
Average ForecastGBX 1,361.60
Low ForecastGBX 1,150
TypeCurrent Forecast
2/12/23 to 2/12/24		1 Month Ago
1/13/23 to 1/13/24		3 Months Ago
11/14/22 to 11/14/23		1 Year Ago
2/12/22 to 2/12/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetGBX 1,361.60GBX 1,361.60GBX 1,444.40GBX 1,408.60
Get Smith & Nephew Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.


SN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Smith & Nephew Stock vs. The Competition

TypeSmith & NephewMedical Companies
Consensus Rating Score
2.83
2.68
Consensus RatingModerate BuyModerate Buy
News Sentiment RatingNeutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/9/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingEqual WeightGBX 1,150+4.40%
11/30/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuyGBX 1,500+46.84%
11/30/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOverweightGBX 1,248+22.17%
11/6/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperformGBX 1,600 ➝ GBX 1,500+52.81%
6/15/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy
3/1/2023Liberum Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeBuyGBX 1,120 ➝ GBX 1,410+18.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 04:01 AM ET.












SN Price Target - Frequently Asked Questions

What is Smith & Nephew's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Smith & Nephew stock is Moderate Buy based on the current 1 hold rating and 5 buy ratings for SN. The average twelve-month price prediction for Smith & Nephew is GBX 1,361.60 with a high price target of GBX 1,500 and a low price target of GBX 1,150. Learn more on SN's analyst rating history.

Do Wall Street analysts like Smith & Nephew more than its competitors?

Analysts like Smith & Nephew more than other Medical companies. The consensus rating score for Smith & Nephew is 2.83 while the average consensus rating score for medical companies is 2.67. Learn more on how SN compares to other companies.

Does Smith & Nephew's stock price have much upside?

According to analysts, Smith & Nephew's stock has a predicted upside of 28.16% based on their 12-month stock forecasts.

What analysts cover Smith & Nephew?

Smith & Nephew has been rated by Barclays, Berenberg Bank, and JPMorgan Chase & Co. in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (LON:SN) was last updated on 2/12/2024 by MarketBeat.com Staff

My Account -